Physician profile
David J Cinats
NPI 1285289918
$35,051.50
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,915 · 2021: $1,812 · 2022: $13K · 2023: $18K · 2024: $93.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $3,303 · Food and Beverage: $1,732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,825.00 |
| Travel and Lodging | $3,302.65 |
| Food and Beverage | $1,732.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $19,854.57 | 2021-2023 | Integra, Tenoglide |
| Medical Device Business Services, INC. | $5,043.32 | 2022-2023 | Na |
| Smith+Nephew, INC. | $4,571.39 | 2020-2023 | Evos, Trigen, Kvac |
| Carbofix Orthopedics INC | $1,674.40 | 2022 | |
| Nuvasive Specialized Orthopedics, INC. | $1,668.21 | 2023 | Precice Intramedullary Limb Lengthening System |
| Fortis Surgical, LLC | $1,200.00 | 2021 | |
| Paragon 28, INC. | $491.69 | 2023 | Portfolio, Monkey Bars, Monkey Rings |
| Stryker Corporation | $321.55 | 2022-2024 | Gamma, Mako |
| Depuy Synthes Sales INC. | $226.37 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cinats listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.